160 related articles for article (PubMed ID: 38760801)
21. The association of metabolic syndrome score trajectory patterns with risk of all cancer types.
Deng L; Liu T; Liu CA; Zhang Q; Song MM; Lin SQ; Wang YM; Zhang QS; Shi HP
Cancer; 2024 Jun; 130(12):2150-2159. PubMed ID: 38462898
[TBL] [Abstract][Full Text] [Related]
22. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
Ahn HJ; Han KD; Choi EK; Jung JH; Kwon S; Lee SR; Oh S; Lip GYH
Cardiovasc Diabetol; 2021 Jan; 20(1):20. PubMed ID: 33468142
[TBL] [Abstract][Full Text] [Related]
23. Changes in Metabolic Syndrome Status are Associated With Altered Risk of Pancreatic Cancer: A Nationwide Cohort Study.
Park JH; Han K; Hong JY; Park YS; Hur KY; Kang G; Park JO
Gastroenterology; 2022 Feb; 162(2):509-520.e7. PubMed ID: 34653420
[TBL] [Abstract][Full Text] [Related]
24. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
[TBL] [Abstract][Full Text] [Related]
26. Association of Metabolic Syndrome With Risk of Lung Cancer: A Population-Based Prospective Cohort Study.
Li M; Cao SM; Dimou N; Wu L; Li JB; Yang J
Chest; 2024 Jan; 165(1):213-223. PubMed ID: 37572975
[TBL] [Abstract][Full Text] [Related]
27. Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study.
Yang T; Chu CH; Hsu CH; Hsieh PC; Chung TC; Bai CH; You SL; Hwang LC; Lin CM; Sun CA
Nephrology (Carlton); 2012 Aug; 17(6):532-8. PubMed ID: 22487238
[TBL] [Abstract][Full Text] [Related]
28. Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study.
Jiang R; Li Z; Wang X; Cai H; Wu S; Chen S; Hu H
Technol Health Care; 2023; 31(4):1235-1244. PubMed ID: 36617800
[TBL] [Abstract][Full Text] [Related]
29. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study.
Hsieh YH; Wu MF; Yang PY; Liao WC; Hsieh YH; Chang YJ; Lin IC
BMC Gastroenterol; 2019 Feb; 19(1):33. PubMed ID: 30782138
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations.
Zheng Y; Xie Z; Li J; Chen C; Cai W; Dong Y; Xue R; Liu C
BMC Cardiovasc Disord; 2021 Feb; 21(1):90. PubMed ID: 33588759
[TBL] [Abstract][Full Text] [Related]
31. Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer.
Kocher NJ; Rjepaj C; Robyak H; Lehman E; Raman JD
World J Urol; 2017 Jan; 35(1):67-72. PubMed ID: 27189620
[TBL] [Abstract][Full Text] [Related]
32. Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
PLoS One; 2018; 13(8):e0202757. PubMed ID: 30142166
[TBL] [Abstract][Full Text] [Related]
33. The impact of metabolic syndrome on chronic kidney disease development. Insights from a big prospective study.
Fanaei SM; Mehran L; Amouzegar A; Masoumi S; Amouzegar A; Azizi F
Eur J Clin Invest; 2023 Apr; 53(4):e13945. PubMed ID: 36576367
[TBL] [Abstract][Full Text] [Related]
34. Sex differences in the association of metabolic syndrome with low back pain among middle-aged Japanese adults: a large-scale cross-sectional study.
Yoshimoto T; Ochiai H; Shirasawa T; Nagahama S; Uehara A; Sai S; Kokaze A
Biol Sex Differ; 2019 Jul; 10(1):33. PubMed ID: 31277712
[TBL] [Abstract][Full Text] [Related]
35. Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study.
Huang D; Shin WK; De la Torre K; Lee HW; Min S; Shin A; Lee JK; Kang D
Gastric Cancer; 2023 Jul; 26(4):481-492. PubMed ID: 37010633
[TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
Blanc-Lapierre A; Spence A; Karakiewicz PI; Aprikian A; Saad F; Parent MΓ
BMC Public Health; 2015 Sep; 15():913. PubMed ID: 26385727
[TBL] [Abstract][Full Text] [Related]
37. Association between metabolic syndrome and risk of incident dementia in UK Biobank.
Qureshi D; Collister J; Allen NE; KuΕΊma E; Littlejohns T
Alzheimers Dement; 2024 Jan; 20(1):447-458. PubMed ID: 37675869
[TBL] [Abstract][Full Text] [Related]
38. All-Cause and Cardiovascular Mortality Among Koreans: Effects of Obesity and Metabolic Health.
Sung KC; Ryu S; Cheong ES; Kim BS; Kim BJ; Kim YB; Chung PW; Wild SH; Byrne CD
Am J Prev Med; 2015 Jul; 49(1):62-71. PubMed ID: 26094228
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Score for Visceral Fat: A reliable indicator of visceral obesity for predicting risk for hypertension.
Feng Y; Yang X; Li Y; Wu Y; Han M; Qie R; Huang S; Wu X; Zhang Y; Liu D; Hu F; Zhang M; Yang Y; Shi X; Lu J; Zhao Y; Hu D
Nutrition; 2022 Jan; 93():111443. PubMed ID: 34563934
[TBL] [Abstract][Full Text] [Related]
40. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
